Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

OBJECTIVE: Patients with diabetes have a higher case fatality rate in myocardial infarction (MI) or stroke than those without diabetes: that is, MI and stroke are more often fatal if diabetes is present. We investigated whether the risk of MI or stroke being fatal in type 2 diabetes can be estimate...

Detaylı Bibliyografya
Asıl Yazarlar:	Stevens, R, Coleman, R, Adler, A, Stratton, I, Matthews, DR, Holman, R
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2004

Benzer Materyaller

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data
Yazar:: Coleman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Silent myocardial infarction is an independent risk factor for fatal myocardial infarction in patients with Type 2 diabetes
Yazar:: Cull, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.
Yazar:: Kothari, V, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.
Yazar:: Keavney, B, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients
Yazar:: Groves, C, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Ethnic differences in diabetic nephropathy - The UKPDS
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Yazar:: Coleman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetes.
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.
Yazar:: Davis, T, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Risk factors for neuropathy in UKPDS
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
Yazar:: Coleman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Yazar:: Coleman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Risk factors for incident albuminuria and renal dysfunction in the UKPDS
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Yazar:: Matthews, DR, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Yazar:: Holman, R, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Yazar:: Adler, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?
Yazar:: Gray, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
Yazar:: Clarke, P, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
Yazar:: Kohner, E, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Incidence and case fatality of acute myocardial infarction in Korea, 2011-2020
Yazar:: Yeeun Seo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Some Facts about Case Fatality of Acute Myocardial Infarction in Iran
Yazar:: Abdollah MOHAMMADIAN-HAFSHEJANI, ve diğerleri
Baskı/Yayın Bilgisi: (2015-12-01)

Life-expectancy projection by modelling and computer simulation (UKPDS 46).
Yazar:: Stevens, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Yazar:: Stratton, I, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
Yazar:: Price, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
Yazar:: Turner, R, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Yazar:: Widjaja, A, ve diğerleri
Baskı/Yayın Bilgisi: (1996)